MedTrace Logo

High Flow Oxygen and Non Invasive Ventilation for Hypercapnic Respiratory Failure

NCT03627598 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-08-13

No results posted yet for this study

Summary

this study evaluates high flow oxygen therapy in addition to non invasive ventilation (NIV) to treat hypercapnic respiratory failure. Between sessions of NIV, half of participants will have high flow nasal cannula while the others will have standard low flow oxygen therapy.

Conditions

  • Hypercapnic Respiratory Failure

Interventions

DEVICE

HFNC

patients will receive high flow warmed air with low inspired fraction of oxygen between non invasive ventilation sessions

DEVICE

standard

patients will receive low flow oxygen therapy at 1 to 4 liters per minute

Sponsors & Collaborators

  • University Hospital, Mahdia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-08-31
Completion
2019-10-31

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03627598 on ClinicalTrials.gov